Ifedayo Victor Ogungbe to Biological Products
This is a "connection" page, showing publications Ifedayo Victor Ogungbe has written about Biological Products.
Connection Strength
2.263
-
Metibemu DS, Ogungbe IV. Carotenoids in Drug Discovery and Medicine: Pathways and Molecular Targets Implicated in Human Diseases. Molecules. 2022 Sep 15; 27(18).
Score: 0.670
-
Zhang H, Collins J, Nyamwihura R, Ware S, Kaiser M, Ogungbe IV. Discovery of a quinoline-based phenyl sulfone derivative as an antitrypanosomal agent. Bioorg Med Chem Lett. 2018 05 15; 28(9):1647-1651.
Score: 0.491
-
Ogungbe IV, Setzer WN. The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking Investigations. Molecules. 2016 Oct 19; 21(10).
Score: 0.445
-
Ogungbe IV, Setzer WN. Comparative molecular docking of antitrypanosomal natural products into multiple Trypanosoma brucei drug targets. Molecules. 2009 Apr 14; 14(4):1513-36.
Score: 0.264
-
Komolafe K, Komolafe TR, Crown OO, Ajiboye B, Noubissi F, Ogungbe IV, Graham B. Natural Products in the Management of Gastroesophageal Reflux Disease: Mechanisms, Efficacy, and Future Directions. Nutrients. 2025 Mar 19; 17(6).
Score: 0.199
-
Coy-Barrera E, Ogungbe IV, Schmidt TJ. Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Therapeutics. Molecules. 2023 Apr 25; 28(9).
Score: 0.175
-
Helms KM, Wilson RC, Ogungbe IV, Setzer WN, Twigg PD. Vitexin inhibits polyubiquitin synthesis by the ubiquitin-conjugating enzyme E2-25K. Nat Prod Commun. 2011 Oct; 6(10):1411-6.
Score: 0.020